Form 4 for CYTK CYTOKINETICS INC
Accepted 2022-07-14 00:00:00 ET · period of report 2022-07-14 · accession 0001127602-22-019304 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-14 | 2022-07-14 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $9.65 | +21.5K | 189.8K | +13% | +$207.5K |
| D | 2022-07-14 | 2022-07-14 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $43.43 | -21.5K | 168.3K | -11% | -$933.7K |
| D | 2022-07-14 | 2022-07-14 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $0.00 | -21.5K | 43.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-14 | M | A | 21,500 | $9.65 | 189,846 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-14 | S | D | 21,500 | $43.43 | 168,346 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2022-07-14 | M | D | 21,500 | $0.00 | 43,013 | D | $9.65 · 2014-03-24 to 2024-02-24 | 21,500 Common Stock |